Facts
as of Nov 16, 2026
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid biopsy. Its Orion spatial proteomics platform enables single-round high-plex immunofluorescence imaging for translational and clinical research.
It is hiring: 2 open roles, 1 of them posted in the last 30 days.
- Legal name
- RareCyte, Inc.
- Headquarters
- Seattle, United States
- Founded
- 2009
- Employees
- 62US Form 5500 (plan participants) · Dec 2024
- Open roles
- 2Alion job postings
- Register numbers
- NAME rarecyte inc
- Website
- rarecyte.com
As of Nov 16, 2026, Alion lists 2 open roles at RareCyte. RareCyte is headquartered in Seattle, United States. It was founded in 2009. It has raised $79.8M in 5 funding rounds. The latest round is Venture - Series Unknown of $13.2M, announced in 2023.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
RareCyte, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring at full speed: most open roles are fresh.
Backend is the largest family, 50 of open roles.
1Posted in 30 days50% of open roles are fresh
0%Remote roles0 of 2
1Hiring offices
Can they hire you from United States?by your location
Likely
2 open roles are in your country: you apply locally, no move needed.
United States2On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand8
Pay34
Your chance44
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Oct 5This week
Open roles a week: 1 then, 0 now
Where the openings areshare of open roles · trend
Newest roles
Senior Software Engineer$150k – $170k per year · Equity · In office · Full-Time · 5+ years exp · Bachelor's Degree · Seattle
Degree asked
Bachelor's Degree 100%
1 postings state a degree.
Benefits named in postingsshare of open roles
Equity2100%
Stock options2100%
Contract type
Full-Time 2
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Pay
What its postings pay, by level.
$165kMedian
$160k – $170kTypical rangeUSD a year
$170kHighest paying roleSenior Software Engineer
Source: the pay stated in the company's postings, normalised to USD a year
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
SeattleBusiest site
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$79.8MTotal raised
$2.9MPublic grants3 public grants
GrantLatest round
8Rounds and grants
Money by yearUSD, rounds and grants
2025$658k1 record
2023$13.2M1 record
2021$24M1 record
2020$2M1 record
2019$22.2M1 record
2018$5.2M2 records
2017$15.4M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers
Tech stack
Technologies named in job postings at RareCyte over the last 12 months, by layer, with the share of postings for each.
19Technologies in use
1Postings analysed
77/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
Aug 21, 20252025
News · YahooFinance
RareCyte, Inc., a leading innovator in precision biology and liquid biopsy technology, is proud to announce receipt of a $500K award from the Gates Foundation to advance research…
Aug 21, 20252025
Press release · marketwatch.com
Jul 1, 20242024
News · Pulse 2.0
RareCyte, a life sciences company offering advanced Precision Biology platforms, including instruments, reagents, software, and services, announced the completion of $20 million…
Jun 27, 20242024
News · GeekWire
Seattle-based life sciences companyRareCyteannounced$20 million in new fundingto advance its applications for the analysis of cells. RareCyte sells
Sources: the outlets named on each headline, each story once